Cover story of JCPS 2021-3.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 266
- Publication type:
- Article
Works matching IS 10031057 AND DT 2021 AND VI 30 AND IP 3
Results: 9
1
2
The research group of Xianrong Qi has made progress in the study of cancer phototherapy and immunotherapy.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 264, doi. 10.1016/j.biomaterials.2020.120648
- Publication type:
- Article
3
Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib, gefitinib, afatinib and osimertinib) as first-line therapy for epidermal growth factor receptor-mutated advanced non-small cell lung cancer.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 253, doi. 10.5246/jcps.2021.03.021
- By:
- Publication type:
- Article
4
Comparison of quality control standards of PET radiopharmaceuticals for tumor in Pharmacopoeia of Europe, the United States and People's Republic of China.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 246, doi. 10.5246/jcps.2021.03.020
- By:
- Publication type:
- Article
5
A simple and sensitive electrochemical impedimetric immunosensor for the detection of apolipoprotein E4 based on CeZnO nanoparticle.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 239, doi. 10.5246/jcps.2021.03.019
- By:
- Publication type:
- Article
6
Extractum trametes robiniophila murr protects murine podocyte via actin cytoskeleton stabilization.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 230, doi. 10.5246/jcps.2021.03.018
- By:
- Publication type:
- Article
7
Tolvaptan, an FDA-approved drug, inhibits Zika virus infection both in vitro and in vivo.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 218, doi. 10.5246/jcps.2021.03.017
- By:
- Publication type:
- Article
8
Pharmacokinetics, pharmacodynamics and safety of a single-dose long-acting Risperidone injection in Chinese patients with schizophrenia.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 206, doi. 10.5246/jcps.2021.03.016
- By:
- Publication type:
- Article
9
Riboflavin-modified lipo-polyplexes co-delivering CXCR4 siRNA and doxorubicin for treatment of highly metastatic cancer.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 3, p. 189, doi. 10.5246/jcps.2021.03.015
- By:
- Publication type:
- Article